# Intraluminal Amoxicillin Powder Monotherapy for Helicobacter Pylori Infection

> **NCT03521726** · PHASE4 · COMPLETED · sponsor: **Mackay Memorial Hospital** · enrollment: 20 (actual)

## Conditions studied

- Helicobacter Pylori Infection

## Interventions

- **DRUG:** Amoxicillin
- **DRUG:** Rabeprazole, Amoxicillin

## Key facts

- **NCT ID:** NCT03521726
- **Lead sponsor:** Mackay Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-05-11
- **Primary completion:** 2019-02-12
- **Final completion:** 2019-02-12
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2019-02-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03521726

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03521726, "Intraluminal Amoxicillin Powder Monotherapy for Helicobacter Pylori Infection". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03521726. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*